A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ONO-4538 Phase I Study in Patients With Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
ONO-4538 Phase I Study in Patients With Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1